Search Count: 22
 |
Organism: Human adenovirus 24
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2023-09-20 Classification: VIRAL PROTEIN |
 |
Organism: Human adenovirus 25
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2023-09-20 Classification: VIRAL PROTEIN Ligands: SO4, EDO, PEG |
 |
Organism: Human adenovirus 25
Method: X-RAY DIFFRACTION Resolution:2.51 Å Release Date: 2023-09-20 Classification: VIRAL PROTEIN Ligands: SLB |
 |
Organism: Human adenovirus 30
Method: X-RAY DIFFRACTION Resolution:2.56 Å Release Date: 2023-09-20 Classification: VIRAL PROTEIN Ligands: SLB |
 |
Organism: Human adenovirus 32
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2023-09-20 Classification: VIRAL PROTEIN |
 |
Organism: Human adenovirus 53
Method: X-RAY DIFFRACTION Resolution:1.61 Å Release Date: 2023-09-20 Classification: VIRAL PROTEIN Ligands: SO4, EDO, PEG |
 |
Organism: Human adenovirus 53
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2023-09-20 Classification: VIRAL PROTEIN Ligands: PEG, EDO, P4G, SLB, SIA |
 |
Human Wee1 Kinase In Complex With Inhibitor 1-[6-(1-Hydroxy-1-Methyl-Ethyl)-Pyridin-2-Yl]-2-(2-Methoxy-Phenyl)-6-[4-(4-Methyl-Piperazin-1-Yl)-Phenylamino]-1,2-Dihydro-Pyrazolo[3,4-D]Pyrimidin-3-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.53 Å Release Date: 2023-05-31 Classification: TRANSFERASE Ligands: QT9 |
 |
Structure Of Human Plk1 In Complex With 2-Allyl-1-[6-(1-Hydroxy-1-Methyl-Ethyl)-Pyridin-2-Yl]-6-[4-(4-Methyl-Piperazin-1-Yl)-Phenylamino]-1,2-Dihydro-Pyrazolo[3,4-D]Pyrimidin-3-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2023-04-26 Classification: TRANSFERASE Ligands: ACT, 8X7, ZN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.32 Å Release Date: 2022-04-06 Classification: IMMUNE SYSTEM Ligands: ZEV |
 |
Organism: Chimpanzee adenovirus y25
Method: ELECTRON MICROSCOPY Release Date: 2021-12-15 Classification: VIRUS |
 |
Organism: Chimpanzee adenovirus y25
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2021-06-23 Classification: VIRAL PROTEIN Ligands: CA, EDO, TRS |
 |
Organism: Human adenovirus 29
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2021-03-31 Classification: VIRAL PROTEIN Ligands: SIA |
 |
Organism: Human adenovirus 29
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-03-31 Classification: VIRAL PROTEIN Ligands: PO4, GOL |
 |
Organism: Human adenovirus d serotype 15
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2021-03-31 Classification: VIRAL PROTEIN |
 |
Organism: Human adenovirus 30
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2020-09-16 Classification: VIRAL PROTEIN Ligands: GLU, EDO |
 |
Crystal Structure Of Hiv Protease Complexed With (S)-N-(3-Fluoro-2-(2-(1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKD |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6R)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKM |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6R)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKS |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,5S)-5-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKV |